Immunocore Holdings plc American Depositary Shares (IMCR) Stock Price, Quote & AI Analysis

Live IMCR stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Immunocore Holdings plc American Depositary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Immunocore Holdings plc American Depositary Shares (IMCR), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

IMCR
Immunocore Holdings plc American Depositary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$1,644,765,138.45
52W Range
$23.15 - $40.71
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 24, 2026 Q4
After Hours
EPS Estimate: $-0.2381
Revenue Estimate: $109,681,620.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Immunocore Holdings plc American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Immunocore Holdings plc American Depositary Shares Overview

Company information

Company Overview

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.

Company Details
Market Cap
$1.67B
Shares Outstanding
50,467,954
Weighted Shares Outstanding
50,530,419
CEO
Bahija Jallal
Address
90 PARK DRIVE, OXFORDSHIRE, X0, OX14 4RY
Employees
493
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Immunocore Holdings plc American Depositary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...